NCT01453101
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
NCT02302495
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Centre Hospitalier H. Duffaut Avignon, France
- Centre Hospitalier de la côte basque Bayonne, France
- Hôpital Jean Minjoz Besançon, France
- Institut Bergonie Bordeaux, France
Completed
Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma
NCT02626481
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- AZ ST Jan hematology department Bruges, Belgium
- Hematologie Laarbeeklaan Brussels, Belgium
- Jules Bordet Institute Brussels, Belgium
- CHU Dinant Godinne | UCL Namur asbl Yvoir, Belgium
NCT00574652
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cryoglobulinemia, +13 more
- Locations
-
- Hôpital de la Pitié Paris, France
NCT05972577
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +49 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01067287
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Rambam Medical Center Haifa, Israel
NCT01502085
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
Completed
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
NCT01813227
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
Completed
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
NCT01242267
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
NCT01315132
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States